Skip to main content
Full access
Letters
Published Online: 1 June 2011

Cognitive Impairment in Mental Illness: An SSA Blind Spot?

To the Editor: The field now recognizes that our patients, particularly those with a diagnosis of schizophrenia, have significant co-occurring cognitive impairment (1). Unfortunately, in our experience at Thresholds, the disability determination process used by the Social Security Administration (SSA) often does not recognize cognitive impairment of individuals with schizophrenia and similar conditions otherwise considered stable (the exception is for the category of patients with dementia, delirium, or amnestic disorders, for whom cognitive impairment is taken into account). SSA does not recognize the importance of cognitive impairment in most mental disorders as a vocational impairment in determining disability.
The current SSA guidelines for determining disability focus heavily on the overt signs and symptoms of mental impairments but do not focus on cognitive impairment. Proposed new rules would deemphasize the signs and symptoms, but there is no evidence of concern about cognitive impairment in schizophrenia and other psychiatric disorders in the proposed rules. The actual vocational disability that results from these disorders is often unrelated to delusions, hallucinations, sadness, or anxiety. Our patients, even when their symptoms have remitted, are left with cognitive impairments that interfere with concentration, attention, visuospatial function, language, memory, and executive function. These are the enduring and disabling features of serious mental illness. There is no good way to demonstrate these impairments unless you test for them.
The Montreal Cognitive Assessment (MoCA) was designed as a rapid test for “mild cognitive impairment” among elderly persons (2). Like the Folstein Mini-Mental State Exam, scores on the MoCA range from 0 to 30. The MoCA takes about 12 minutes to administer. For persons with no cognitive impairment, MoCA scores averaged 27.4±2.2. Persons with known dementia of the Alzheimer type had MoCA scores that averaged 16.2±4.8. Persons with “mild cognitive impairment” had MoCA scores that averaged 22.1±3.1.
In a 2010 study at Thresholds, we administered the MoCA and the Folstein Mini-Mental State Exam to 112 stable individuals with schizophrenia (Wilkniss S, Teachout A, Robin L, et al., unpublished manuscript, 2010). The mean±SD MoCA score of persons with schizophrenia was 22.7±4.3. This score falls squarely into the “mild cognitive impairment” range observed with an elderly sample. On the Folstein Mini-Mental State Exam, the same individuals had a score of 27.1±2.5, which is in the normal range.
As part of preparing a report for SSA, we also administered the MoCA to 224 individuals seen for consecutive psychiatric evaluations. The group had a wide range of diagnoses. We cannot validate the representativeness of the sample with respect to all individuals who apply to SSA for disability benefits; however, we did nothing to specially select the sample. We were surprised by the high rates of cognitive impairment across all diagnostic categories. [A table with mean MoCA scores for patients in the main diagnostic categories is available in an online supplement to this letter at ps.psychiatryonline.org.]
On the basis of our experience, we propose that SSA recognize cognitive impairment as a common work-related impairment in a wide range of mental disorders not confined to dementia, delirium, or amnestic disorders. Failure to do so risks inappropriate denials of disability benefits. Physicians reporting to SSA need to perform more sophisticated cognitive testing. The SSA guidelines should accommodate the concept of co-occurring cognitive impairment in all diagnostic categories. Adjudicators and administrative law judges need to be educated about this phenomenon. At the same time, strategies to facilitate recovery and exit from the disability roll must target cognitive impairment and remediation of cognitive deficits.

Acknowledgments and disclosures

The author reports no competing interests.

Supplementary Material

File (Amdur_ds.pdf)

References

1.
Keefe RSE, Fenton WS: How should DSM-V criteria for schizophrenia include cognitive impairment? Schizophrenia Bulletin 33:912–920, 2007
2.
Nasreddine ZS, Phillips NA, Bédirian V, et al.: The Montreal Cognitive Assessment (MoCA): a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society 53:695–699, 2005

Information & Authors

Information

Published In

Go to Psychiatric Services
Go to Psychiatric Services
Cover: Hurricane Island, Vinalhaven, Maine, by Marsden Hartley, 1942. Oil on masonite, 30 × 39 15/16 inches. Gift of Mrs. Herbert Cameron Morris, 1943. Philadelphia Museum of Art.
Psychiatric Services
Pages: 682
PubMed: 21632742

History

Published online: 1 June 2011
Published in print: June 2011

Authors

Affiliations

Mark A. Amdur, M.D.
Dr. Amdur is senior psychiatric consultant at Thresholds, Chicago.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Psychiatric Services

PPV Articles - Psychiatric Services

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share